SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016129
Filing Date
2022-11-03
Accepted
2022-11-03 07:05:34
Documents
62
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q thrx-20220930x10q.htm   iXBRL 10-Q 1521451
2 EX-31.1 thrx-20220930xex31d1.htm EX-31.1 15020
3 EX-31.2 thrx-20220930xex31d2.htm EX-31.2 15235
4 EX-32.1 thrx-20220930xex32d1.htm EX-32.1 8032
5 EX-32.2 thrx-20220930xex32d2.htm EX-32.2 8025
  Complete submission text file 0001558370-22-016129.txt   5929071

Data Files

Seq Description Document Type Size
6 EX-101.SCH thrx-20220930.xsd EX-101.SCH 33025
7 EX-101.CAL thrx-20220930_cal.xml EX-101.CAL 37974
8 EX-101.DEF thrx-20220930_def.xml EX-101.DEF 162350
9 EX-101.LAB thrx-20220930_lab.xml EX-101.LAB 356927
10 EX-101.PRE thrx-20220930_pre.xml EX-101.PRE 283861
56 EXTRACTED XBRL INSTANCE DOCUMENT thrx-20220930x10q_htm.xml XML 990187
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Filer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40869 | Film No.: 221356150
SIC: 2834 Pharmaceutical Preparations